Related references
Note: Only part of the references are listed.Are immunotherapies for Huntington's disease a realistic option?
Helena L. Denis et al.
MOLECULAR PSYCHIATRY (2019)
Involvement of Aryl hydrocarbon receptor in myelination and in human nerve sheath tumorigenesis
Ghjuvan Ghjacumu Shackleford et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Early pridopidine treatment improves behavioral and transcriptional deficits in YAC128 Huntington disease mice
Marta Garcia-Miralles et al.
JCI INSIGHT (2017)
Disruption of immune cell function by mutant huntingtin in Huntington's disease pathogenesis
Ralph Andre et al.
CURRENT OPINION IN PHARMACOLOGY (2016)
Laquinimod decreases Bax expression and reduces caspase-6 activation in neurons
Dagmar E. Ehrnhoefer et al.
EXPERIMENTAL NEUROLOGY (2016)
Structural and molecular myelination deficits occur prior to neuronal loss in the YAC128 and BACHD models of Huntington disease
Roy Tang Yi Teo et al.
HUMAN MOLECULAR GENETICS (2016)
Laquinimod arrests experimental autoimmune encephalomyelitis by activating the aryl hydrocarbon receptor
Joel Kaye et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Laquinimod rescues striatal, cortical and white matter pathology and results in modest behavioural improvements in the YAC128 model of Huntington disease
Marta Garcia-Miralles et al.
SCIENTIFIC REPORTS (2016)
Early white matter abnormalities, progressive brain pathology and motor deficits in a novel knock-in mouse model of Huntington's disease
Jing Jin et al.
HUMAN MOLECULAR GENETICS (2015)
Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriers
Marios Politis et al.
NEUROBIOLOGY OF DISEASE (2015)
The choreography of neuroinflammation in Huntington's disease
Andrea Crotti et al.
TRENDS IN IMMUNOLOGY (2015)
Huntington disease
Gillian P. Bates et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Laquinimod, an up-and-coming immunomodulatory agent for treatment of multiple sclerosis
Michel Varrin-Doyer et al.
EXPERIMENTAL NEUROLOGY (2014)
Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination
Wolfgang Brueck et al.
ACTA NEUROPATHOLOGICA (2012)
Modulation of Autoimmune Demyelination by Laquinimod via Induction of Brain-Derived Neurotrophic Factor
Jan Thoene et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice
Mahmoud A. Pouladi et al.
HUMAN MOLECULAR GENETICS (2012)
Mutant huntingtin fragmentation in immune cells tracks Huntington's disease progression
Andreas Weiss et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Oral treatment with laquinimod augments regulatory T-cells and brain-derived neurotrophic factor expression and reduces injury in the CNS of mice with experimental autoimmune encephalomyelitis
Rina Aharoni et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
Kynurenine 3-Monooxygenase Inhibition in Blood Ameliorates Neurodegeneration
Daniel Zwilling et al.
CELL (2011)
Microglial activation in regions related to cognitive function predicts disease onset in Huntington's Disease: A multimodal imaging study
Marios Politis et al.
HUMAN BRAIN MAPPING (2011)
Peroxisome-Proliferator-Activated Receptor Gamma Coactivator 1 α Contributes to Dysmyelination in Experimental Models of Huntington's Disease
Zhongmin Xiang et al.
JOURNAL OF NEUROSCIENCE (2011)
Natural history of disease in the YAC128 mouse reveals a discrete signature of pathology in Huntington disease
Jeffrey B. Carroll et al.
NEUROBIOLOGY OF DISEASE (2011)
Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin
Mahmoud A. Pouladi et al.
BRAIN (2009)
In vivo measurement of axon diameter distribution in the corpus callosum of rat brain
Daniel Barazany et al.
BRAIN (2009)
Myelin Proteomics: Molecular Anatomy of an Insulating Sheath
Olaf Jahn et al.
MOLECULAR NEUROBIOLOGY (2009)
Tests to assess motor phenotype in mice: a user's guide
Simon P. Brooks et al.
NATURE REVIEWS NEUROSCIENCE (2009)
A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease
Maria Bjorkqvist et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Microglial activation in presymptomatic Huntington's disease gene carriers
Yen F. Tai et al.
BRAIN (2007)
Microglial activation correlates with severity in Huntington disease - A clinical and PET study
N. Pavese et al.
NEUROLOGY (2006)
Selective degeneration and nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease
JM Van Raamsdonk et al.
HUMAN MOLECULAR GENETICS (2005)
Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease
JM Van Raamsdonk et al.
JOURNAL OF NEUROSCIENCE (2005)
Biology of oligodendrocyte and myelin in the mammalian central nervous system
N Baumann et al.
PHYSIOLOGICAL REVIEWS (2001)
Early and progressive accumulation of reactive microglia in the Huntington disease brain
E Sapp et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2001)
Share Paper
